AmifostinePaclitaxelRadiation-Protective AgentsRadiotherapyRadiotherapy DosageMercaptoethylaminesRadiotherapy, ConformalRadiotherapy, AdjuvantAntineoplastic Agents, PhytogenicCombined Modality TherapyRadiation InjuriesRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedDose FractionationAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, High-EnergyTreatment OutcomeCarboplatinDrug Administration ScheduleCisplatinRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedLung NeoplasmsHead and Neck NeoplasmsXerostomiaAntineoplastic AgentsDisease-Free SurvivalDoxorubicinNeoplasm StagingBreast NeoplasmsDose-Response Relationship, RadiationSurvival RateRadiation DosageRadiation OncologyNeoplasm Recurrence, LocalInfusions, IntravenousNeoplasmsCarcinoma, Squamous CellCarcinoma, Non-Small-Cell LungSurvival AnalysisStomatitisTime FactorsOrgans at RiskRadiosurgeryDose-Response Relationship, DrugOvarian NeoplasmsRadiation ToleranceChemoradiotherapyRadiation Injuries, ExperimentalTaxoidsCyclophosphamideRadiation-Sensitizing AgentsBrachytherapyMaximum Tolerated DoseChemotherapy, AdjuvantBrain NeoplasmsRetrospective StudiesRadiometryFollow-Up StudiesNeutropeniaNasopharyngeal NeoplasmsVinblastineCell Line, TumorProstatic NeoplasmsDrug Resistance, NeoplasmPrognosisFluorouracilTubulin ModulatorsCytoprotectionDrug SynergismThoracic NeoplasmsVincristineFeasibility StudiesDeoxycytidineSamariumTesticular DiseasesMicroradiographyAdenocarcinomaRectal NeoplasmsArea Under CurvePeripheral Nervous System DiseasesCarcinoma